Assistant Professor Dr. Fatokun Omotayo Oladuntoye

Assistant Professor Dr. Omotayo Oladuntoye Fatokun

Head of Department, Clinical Pharmacy | Department of Clinical Pharmacy

Academic Qualifications

M. Pharm. (Clinical Pharmacy and Biopharmacy)
Bachelor of Pharmacy (Hons)

Areas of Interest
Pharmaceutical Health Services and Policy
Pharmacoepidemiology and Drug Safety
Professional Bodies

  1. Registered Pharmacist, Pharmacists Council of Nigeria
  2. Member, International Society of Pharmacoepidemiology (ISPE)
  3. Member, International Society of Pharmacoeconomics and Outcomes Research (ISPOR)


Research project




Evaluation of the utilization and provision of written medicine information (WMI) among consumers, community pharmacists and private general practitioners in Klang Valley, Malaysia

Pioneer Scientist Incentive Fund (PSIF)




Formulation and Clinical Evaluation of Mangosteen And Seaweed- Impregnated Bio-Cellulose Facial Mask for Anti-Aging and Anti-Acne Effects

Pioneer Scientist Incentive Fund (PSIF)






Master students (Completed)

  • Khadija Mallouk (2019)
  • Chang Lina (2018)
  • Mooi Xin Yi (2018)
  • Alice Ew Shu Min (2018)
  • Nithya A/P Palani (2018)
  • Anabelle Rose Joykin (2018)
  • Hari Pretha Nair A/P Raghvan (2018)


Book Chapter

  • Fatokun, O. (2018). Assessment of Policies, Determinants, and Characteristics of Generic Medicines Entry into the Pharmaceutical Markets. In Social and Administrative Aspects of Pharmacy in Low-and Middle-Income Countries: Present Challenges and Future Solutions (pp. 211–225). Elsevier Inc.


Journal Articles

  • Fatokun, O. (2017). Cancer control reform in Nigeria. The Lancet Oncology. Lancet Publishing Group.
  • Fatokun, O. (2016). Curbing the circulation of counterfeit medicines in Nigeria. The Lancet. Lancet Publishing Group.
  • Fatokun, O. Olawepo, MN. (2016) Factors associated with prescribing restriction on oncology formulary drugs in Malaysia. International Journal of Clinical Pharmacy, 38 (5), 1075-1079.
  • Fatokun, O. (2014). Exploring antibiotic use and practices in a Malaysian community. International Journal of Clinical Pharmacy36(3), 564–569.
  • Khan, M. U., Shah, S., Ahmad, A., & Fatokun, O. (2014). Knowledge and attitude of healthcare workers about middle east respiratory syndrome in multispecialty hospitals of Qassim, Saudi Arabia. BMC Public Health14(1).
  • Fatokun, O., Ibrahim, M. I. M., & Hassali, M. A. (2013). Factors determining the post-patent entry of generic medicines in Malaysia: A survey of the Malaysian generic pharmaceutical industry. Journal of Generic Medicines10(1), 22–33.
  • Fatokun, O., Ibrahim, M. I. M., & Hassali, M. A. (2013). Generic industry’s perceptions of generic medicines policies and practices in Malaysia. Journal of Pharmacy Research7(1), 80–84. Retrieved from
  • Fatokun, O., Ibrahim, M. I. M., & Hassali, M. A. A. (2013). Time to entry of generic medicines in Malaysia: Implications for pharmaceutical cost containment. Journal of Pharmaceutical Health Services Research4(4), 203–210.
  • Fatokun, O., Ibrahim, M. I. M., & Hassali, M. A. (2011). Generic competition and drug prices in the Malaysian off-patent pharmaceutical market. Journal of Applied Pharmaceutical Science1(9), 33–37.

Journal Reviewers

  1. Value in Health Regional Issues
  2. Bulletin of the World Health Organization
  3. Journal of Pharmaceutical Health Services Research